BioLineRx (BLRX) Asset Utilization Ratio (2023 - 2025)
Historic Asset Utilization Ratio for BioLineRx (BLRX) over the last 3 years, with Q3 2025 value amounting to 0.31.
- BioLineRx's Asset Utilization Ratio fell 123.42% to 0.31 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.31, marking a year-over-year decrease of 123.42%. This contributed to the annual value of 0.56 for FY2024, which is N/A changed from last year.
- BioLineRx's Asset Utilization Ratio amounted to 0.31 in Q3 2025, which was down 123.42% from 0.4 recorded in Q2 2025.
- Over the past 5 years, BioLineRx's Asset Utilization Ratio peaked at 0.63 during Q4 2024, and registered a low of 0.02 during Q4 2023.
- In the last 3 years, BioLineRx's Asset Utilization Ratio had a median value of 0.31 in 2024 and averaged 0.33.
- As far as peak fluctuations go, BioLineRx's Asset Utilization Ratio skyrocketed by 290048.96% in 2024, and later plummeted by 123.42% in 2025.
- BioLineRx's Asset Utilization Ratio (Quarter) stood at 0.02 in 2023, then skyrocketed by 2900.49% to 0.63 in 2024, then tumbled by 51.45% to 0.31 in 2025.
- Its Asset Utilization Ratio stands at 0.31 for Q3 2025, versus 0.4 for Q2 2025 and 0.54 for Q1 2025.